| | - Industry-specific imp
'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved | |
Page: 1 2 3
Related biology technology :
1. PharmSource Adds New Capabilities to the PharmSource ADVANTAGE Online Service
2. PharmSource and BioProcess Technology Consultants Announce Publication of New Market Report: Cell Culture Manufacturing Capacity: Trends and Outlook through 2013
3. PharmSource President Moderates Videocast on Outsourcing to Asia at AAPS
4. PharmSource Introduces Proprietary Resource for Identifying New Business Opportunities in Bio/Pharma
5. CEL-SCI Corporation Releases Letter to Shareholders
6. Elsevier Releases Results of Alternative Energy Research Leadership Study Identifying Top 25 Institutions Worldwide
7. A-WIT Technologies Releases World's First Low Cost C Stamp(TM) Based Biotechnology Laboratory in a Box
8. Clontech Laboratories, Inc. Releases the Xfect(TM) and Xfect(TM) Stem Transfection Reagents
9. Nucletron Releases Comprehensive Film-and Volume-Based Planning System for Wide Variety of Brachy Solutions
10. ZyGEM Releases Application Note Showing its DNA Extraction Kits Rapidly Produce High Yields of Quality DNA
11. Techne Corporation Releases Unaudited Third Quarter Results for Fiscal Year 2009
(Date:11/24/2009)... , REYKJAVIK, Iceland, November.... (Nasdaq: DCGN ) today announced that it has rece...ing in the company,s common stock will be,suspende...e filed with the,Securities and Exchange Commissio...sting on Nasdaq, unless the company files an appea... (Date:11/24/2009)... , REYKJAVIK, Iceland, November.... (Nasdaq: DCGN ) today announced the approval of ...tcy Court for the District of Delaware,(the "Bankr...petition for,relief under Chapter 11 of the United... , The orders issued by the Bankruptcy Co... (Date:11/24/2009)... , SHANGHAI, Nov. 24 /PRNewswire-Asia/ ...od & Drug Administration (SFDA) has approved t...its oral insulin project,(Nodlin), an innovative i...roval allows Biolaxy to initiate its first phase I... characteristic of high blood glucose and poor,met... (Date:11/24/2009)... , , Primary efficacy endpoint has been met ...endometrial cancer, , QUEBEC CITY, Nov. 24 /P...AQ: AEZS ; TSX: AEZ) (the "Company"), a global bi...py and oncology, today announced positive efficacy...oxic peptide conjugate, AEZS-108 (formerly AN-152)... Breaking Biology Technology:deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 2deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 3deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 2deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 3Biolaxy Secures IND Approval for Oral Insulin 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4... Alba Therapeutics Corporation,today announced th...cutive,Officer (CEO) and a member of its Board of ...V Life Sciences Advisors, LLC. Previously, he serv...ment team for several,successful entrepreneurial h...ostic and service areas including The Little Clini... ...A policy comment in Science,today quotes Genelex o...ims about the utility of CYP450,testing for partic...macogenetic testing is "required to effectively pr...ssional/paxil.html )., The actual statement is:, ... Pharmacogenetic,testing of this pathway serves as... ...reement to Produce Reference Standard Reagents to ...EWARK, Del., April 3, 2008 Strategic,Diagnostics ...anced antibody,products and services to the life s...ed by Science Applications International Corporati...ibodies for the Proteomics Reagents &,Resources co... Other Biology Technology:Alba Therapeutics Announces Appointment of Bruce A. Peacock as its Chief Executive Officer 2Science Fuels DNA Testing Controversy with Prejudicial Misquote 2Strategic Diagnostics Inc. Selected as Key Supplier to SAIC-F and the National Cancer Institute for the Development of a Comprehensive Portfolio of Antibodies for Use in Cancer Research 2Strategic Diagnostics Inc. Selected as Key Supplier to SAIC-F and the National Cancer Institute for the Development of a Comprehensive Portfolio of Antibodies for Use in Cancer Research 3(Date:11/24/2009)...K (November 24, 2009) -- The Wildlife Conservation...that the last remaining population of Siberian tig...ising tide of poaching and habitat loss. , ...n officials of what needs to be done to protect re..., The report was released by the Sibe... (Date:11/24/2009)...ble in Spanish . , The presence of increase...atory substances in the blood, hinders the loss an...ch project of the University of Navarra conducted ...hool of Pharmacy. , The project, entitled "A nut...e control of body weight and inflammation," examin... (Date:11/23/2009)... 2009 - The time of day matters to forest trees de...ced by a research team led by Professor Malcolm Ca...rincipal for research and colleagues in the depart... campus. , Capitalizing on their previous work...arch team examined how poplar trees use their 45,0... Breaking Biology News(10 mins):Report shows dramatic decline in Siberian tigers 2It can be predicted the reaction obese patients will have to a diet 2Time of day matters to thirsty trees, U of T researcher discovers 2Senators Kohl and Feingold Vote to Protect Americas Kids From Tobacco 48691 1Senators Kohl and Feingold Vote to Protect Americas Kids From Tobacco 48691 2Senators Baucus and Tester Vote to Protect Americas Kids From Tobacco 48688 1Senators Baucus and Tester Vote to Protect Americas Kids From Tobacco 48688 2Senators Levin and Stabenow Vote to Protect Americas Kids from Tobacco 48685 1Senators Levin and Stabenow Vote to Protect Americas Kids from Tobacco 48685 2...d on the messages it receives from its genome. Som...d in most cell types these delayed messages are st...dies (processing bodies). P bodies in worm egg cel...a paper by Boag et al. to be published in the Aug ...separate study Noble et al. report that worm eggs ... ...., a fully,integrated critical care biotherapeutic...Drug Administration (FDA) has granted orphan drug ... the reduction of the incidence and,severity of de...solid organ,transplantation., Ralf Rosskamp, M.D....ment for Ikaria, commented, "The designation of or... ... variants responsible for body shape. Based on wor...ch published today in the open access journal BMC...an LAMA5 gene as a key determinant of weight. , A...blems continues to increase worldwide, there is co...c mechanisms that control fat storage. Maria De Lu... Other Biology News:Ikaria(R) Receives FDA Orphan Drug Designation for Inhaled Carbon Monoxide for Delayed Graft Function in Solid Organ Transplants 2Rabbit Anti-Human ADAMTS16 Polyclonal Antibody, Unconjugated from Abcam Mouse Anti-Human Actopaxin, phospho (Ser8) Monoclonal Antibody, Unconjugated, Clone J160-366 from BD Biosciences Pharmingen Mouse Anti-Hamartin Monoclonal Antibody, Unconjugated, Clone 1B2 from Cell Signaling Technology Mouse Anti-Mouse Ly 6C.2(Ly 28.2) Monoclonal Antibody, Unconjugated, Clone 5075-3.6 from CEDARLANE Laboratories Limited Biology Products:
|
